dentalcorp (DNTL) AGM 2025 summary
Event summary combining transcript, slides, and related documents.
AGM 2025 summary
30 May, 2026Opening remarks and agenda
Meeting held virtually to enable broader shareholder participation and ensure equal voting and question opportunities for all, regardless of location.
Six formal business matters were outlined: presentation of financial statements, election of directors, reappointment of auditors, and approval of amendments to equity incentive, legacy option, and deferred share unit plans.
Shareholders were instructed on how to submit questions and vote online, with technical support available.
Board and executive committee updates
Eight directors nominated for election, with Kelly Marshall nominated for the first time and Sandra Bosela not standing for re-election.
Recognition given to Sandra Bosela for 11 years of service.
Shareholder proposals
Amendments to the equity incentive plan to increase the maximum number of subordinate voting shares, allow option surrender for shares, and provide for RRSP matching program.
Amendments to the legacy option plan to allow surrender of options for shares at equal in-the-money value.
Amendments to the deferred share unit plan to increase the maximum number of issuable units.
Latest events from dentalcorp
- Arrangement to acquire all shares for CAD 11 each approved, pending court and closing conditions.DNTL
EGM 20253 Feb 2026 - Q2 revenue and EBITDA grew double digits, with CDCP boosting patient volumes and outlook strong.DNTL
Q2 20242 Feb 2026 - Strong M&A-driven growth, high recurring revenue, and positive outlook define the Canadian dental sector.DNTL
Morgan Stanley 22nd Annual Global Healthcare Conference22 Jan 2026 - Double-digit growth, margin expansion, and strong cash flow conversion in Q3 2024.DNTL
Q3 202415 Jan 2026 - 2024 revenue up 8.4% to $1.55B, margin at 18.5%, and 2025 outlook strong.DNTL
Q4 202425 Dec 2025 - Q2 revenue rose 8.9% with 9.9% EBITDA growth, margin expansion, and guidance reaffirmed.DNTL
Q2 202523 Nov 2025 - Q1 2025 saw double-digit EBITDA growth, margin expansion, and record free cash flow.DNTL
Q1 202521 Nov 2025 - Double-digit growth, margin expansion, and AI innovation drive leadership in Canadian dentistry.DNTL
Stifel Jaws & Paws Conference 202521 Nov 2025 - Revenue and EBITDA rose double digits; company to be acquired by GTCR at a 33% premium.DNTL
Q3 20256 Nov 2025